Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

InSite Vision researchers prepare ophthalmic compositions of oxazolidinones

April 26, 2001

Lumigan introduced following mid-March approval by FDA

April 26, 2001

New PKC activators useful for ocular hypertension, glaucoma, etc.

April 4, 2001

Travatan launch quickly follows first approval in U.S.

April 4, 2001

Lumigan: a potent, long-acting and safe new IOP-lowering drug

April 2, 2001

Recently approved IOP-lowering prostaglandin highlighted at Prague glaucoma meeting

March 29, 2001

ROCK inhibitors investigated for potential as antiglaucoma drugs

March 29, 2001

Expanded use of Visudyne approved in E.U.

March 27, 2001

Iomed and Santen to develop treatment of posterior eye diseases

March 26, 2001

Two new antiglaucoma drugs approved by FDA

March 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...